D. Graeme Thomas: 1937-2024
08/20/2024
D. Graeme Thomas, former executive director of Saint Louis University’s Research Innovation Group, died Sunday, Aug. 11. He was 86.
Thomas joined SLU in 2011 as the director of the Office of Technology Management. That role changed in 2017 during an Office of the Vice President for Research reorganization, and Thomas became the executive director of Saint Louis University’s Research Innovation Group.
D. Graeme Thomas. SLU File Photo.
As the executive director, Thomas was responsible for commercializing the products of SLU research, including all aspects of IP protection, contract management, and industry collaboration.
Ray Tait, Ph.D., professor emeritus of psychiatry, was the Vice President of Research when Thomas joined SLU.
“When he was hired to run the Office of Technology Management, he inherited an office in disarray with little recognition among University faculty nor the St. Louis community at large,” Tait said. “Because of his prior work in the start-up community, he immediately brought recognition to the broader community. Due to the successful commercialization of research discoveries made by the SLU faculty, as well as his honesty, insightfulness, and humor (as well as some savvy hires), he earned recognition and respect within the SLU community, too. In short, OTM prospered under his leadership, benefiting both SLU and the broader community. He will be missed.”
While at SLU, Thomas assisted with the spin-out and support of numerous startup businesses based on SLU research and development. The businesses include startups engaged in the development of drugs for the treatment of fibrotic disease, (Indalo Therapeutics, Inc.,) for non-opioid pain relief (BioIntervene Inc.,) and for HSV and fungal infections and hepatitis B (Casterbridge Pharmaceuticals, Inc.).
Thomas was also engaged in the commercialization of drugs developed for use in the treatment of rare diseases including MPS VII enzyme deficiencies and FSHD muscular dystrophies, both licensed to an established, publicly listed, strategic licensee dedicated to the treatment of ultra-rare diseases.
Daniela Salvemini, Ph.D., the William Beaumont Professor and chair of the Department of Pharmacology and Physiology, professor in the Department of Psychiatry and Behavioral Neuroscience, and founding director of the Institute for Translational Science at SLU, worked closely with Thomas.
“Graeme was a close colleague and friend,” Salvemini said. “He supported our endeavors to commercialize our technologies, took a deep interest in the science behind the discoveries and contributed to our mission to discover new pain therapeutics that would help alleviate human suffering. Graeme was a kind man and will be terribly missed.”
Thomas led additional initiatives within SLU including the spin-out of a joint-venture CRO focused on PK/PD studies (Gateway Laboratories) in partnership with an executive of the former Center for World Health & Medicine (CWHM). He later led the repositioning within SLU of ongoing drug development programs formerly conducted within CWHM.
Thomas was also responsible for the promotion and expansion of the University’s sponsored research initiative, for the formation and management of a series of funded research innovation initiatives, and for the direction and oversight of MEDLaunch, SLU’s student-led, student-driven biomedical incubator.
“With his passing, we have lost a true gentleman and scholar, as well as a man with an ethical compass and an acute business sense,” Tait said.
Thomas was born Dec. 9, 1938, in Melbourne, Australia. He completed higher education at Melbourne, Macquarie and RMIT Universities.
Prior to joining the team at SLU, Thomas served in a variety of roles outside higher education. He had leadership roles at Sherwood Medical, MedAcscent Group, Akermin, and CardiaLen. It was that background that helped his work at SLU.
A memorial service is scheduled for Saturday, Sept. 14, 2024, at Kirk of the Hills Presbyterian Church in Town and Country. A visitation will be at 10 a.m. with services to follow at 11 a.m.
Latest Newslink
- SLU/YouGov Poll: Voters say Economy, Abortion, and Criminal Justice/Public Safety Are the Most Important Issues in 2024 Missouri Governor’s RaceMissouri voters will hear from gubernatorial candidates Lt. Governor Mike Kehoe and Representative Crystal Quade Friday, Sept. 20, in the first debate in the race for Missouri governor. The SLU/YouGov Poll asked 450 likely Missouri voters in August: “What issue in the 2024 Election is the most important factor in your vote for Governor of Missouri?” Voters then answered in their own words what was important to them when voting for Governor.
- SLU Researchers Identify Sex-Based Differences in Immune Responses Against TumorsResearchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune system, which is part of the body's "smart system" that monitors for threats and fights them with customized defenses.
- Department of Energy Awards Saint Louis University Nearly $1 Million to Create a Climate Resilience CenterSaint Louis University has received a $964,848 grant from the U.S. Department of Energy (DOE) to create a Climate Resilience Center at SLU. The project is one of 10 centers funded by the DOE in states nationwide.
- SLU’s Farzana Hoque Named a YWCA Metro St. Louis 2024 Leader of DistinctionNominees are put forth by their peers and selected by an independent panel based on their professional achievements and contributions to the community. Farzana Hoque, M.D., associate professor of internal medicine and acting internship co-director, will be honored at the 44th Annual YWCA Leader Lunch on Friday, Dec. 13.
- SLU’s Alec Pollard Receives International OCD Foundation Outstanding Career Achievement AwardAlec Pollard, Ph.D., professor emeritus of family and community medicine, recently received the International OCD Foundation (IOCDF)’s 2024 Outstanding Career Achievement Award. The IOCDF Awards recognize exceptional individuals and professionals for their dedicated efforts in advancing awareness, advocacy, and understanding of obsessive-compulsive disorder.
- SLU Pregnancy Loss Researcher Denise Côté-Arsenault Receives Fulbright Specialist Program AwardDenise Côté-Arsenault, Ph.D., the Hemak Endowed professor of maternal child nursing, has received a Fulbright Specialist Program award, the U.S. Department of State and the Fulbright Foreign Scholarship Board recently announced.